O	0	1	[	[	(	O
O	1	11	Activation	Activation	NN	B-NP
O	12	14	of	of	IN	B-PP
O	15	21	sterol	sterol	NN	B-NP
O	22	32	regulatory	regulatory	JJ	I-NP
O	33	40	element	element	NN	I-NP
O	41	48	binding	binding	NN	I-NP
O	49	56	protein	protein	NN	I-NP
O	57	60	and	and	CC	O
O	61	64	its	its	PRP$	B-NP
O	65	76	involvement	involvement	NN	I-NP
O	77	79	in	in	IN	B-PP
B-Cell	80	91	endothelial	endothelial	JJ	B-NP
I-Cell	92	96	cell	cell	NN	I-NP
O	97	106	migration	migration	NN	I-NP
O	106	107	]	]	)	O

O	108	117	OBJECTIVE	OBJECTIVE	NN	B-NP
O	117	118	:	:	:	O
O	119	121	To	To	TO	B-VP
O	122	127	study	study	VB	I-VP
O	128	131	the	the	DT	B-NP
O	132	142	activation	activation	NN	I-NP
O	143	145	of	of	IN	B-PP
O	146	152	sterol	sterol	NN	B-NP
O	153	163	regulatory	regulatory	JJ	I-NP
O	164	171	element	element	NN	I-NP
O	172	179	binding	binding	NN	I-NP
O	180	187	protein	protein	NN	I-NP
O	188	189	(	(	(	O
O	189	194	SREBP	SREBP	NN	B-NP
O	194	195	)	)	)	O
O	196	199	and	and	CC	O
O	200	203	its	its	PRP$	B-NP
O	204	212	critical	critical	JJ	I-NP
O	213	217	role	role	NN	I-NP
O	218	220	in	in	IN	B-PP
B-Cell	221	232	endothelial	endothelial	JJ	B-NP
I-Cell	233	237	cell	cell	NN	I-NP
O	238	247	migration	migration	NN	I-NP
O	247	248	.	.	.	O

O	249	256	METHODS	METHODS	NNS	B-NP
O	256	257	:	:	:	O
O	258	264	Bovine	Bovine	JJ	B-NP
B-Cell	265	271	aortic	aortic	JJ	I-NP
I-Cell	272	283	endothelial	endothelial	JJ	I-NP
I-Cell	284	289	cells	cell	NNS	I-NP
O	290	291	(	(	(	O
B-Cell	291	294	ECs	EC	NNS	B-NP
O	294	295	)	)	)	O
O	296	300	were	be	VBD	B-VP
O	301	309	cultured	culture	VBN	I-VP
O	309	310	.	.	.	O

O	311	314	The	The	DT	B-NP
O	315	325	expression	expression	NN	I-NP
O	326	328	of	of	IN	B-PP
O	329	334	SREBP	SREBP	NN	B-NP
O	335	338	and	and	CC	I-NP
O	339	344	Cdc42	Cdc42	NN	I-NP
O	345	349	were	be	VBD	B-VP
O	350	360	determined	determine	VBN	I-VP
O	361	363	by	by	IN	B-PP
O	364	371	Western	Western	JJ	B-NP
O	372	376	blot	blot	NN	I-NP
O	377	380	and	and	CC	O
O	381	393	quantitative	quantitative	JJ	B-NP
O	394	398	real	real	JJ	I-NP
O	398	399	-	-	HYPH	I-NP
O	399	403	time	time	NN	I-NP
O	404	407	PCR	PCR	NN	I-NP
O	407	408	.	.	.	O

O	409	417	Moreover	Moreover	RB	B-ADVP
O	417	418	,	,	,	O
O	419	426	outward	outward	JJ	B-NP
O	427	433	growth	growth	NN	I-NP
O	434	443	migration	migration	NN	I-NP
O	444	449	model	model	NN	I-NP
O	450	453	and	and	CC	O
O	454	463	transwell	transwell	VB	B-VP
O	464	471	chamber	chamber	NN	B-NP
O	472	477	assay	assay	NN	I-NP
O	478	482	were	be	VBD	B-VP
O	483	487	used	use	VBN	I-VP
O	488	490	to	to	TO	B-VP
O	491	497	detect	detect	VB	I-VP
B-Cell	498	501	ECs	EC	NNS	B-NP
O	502	511	migration	migration	NN	I-NP
O	511	512	.	.	.	O

O	513	520	RESULTS	RESULTS	NNS	B-NP
O	520	521	:	:	:	O
O	522	523	(	(	(	B-LST
O	523	524	1	1	LS	I-LST
O	524	525	)	)	)	O
O	526	531	SREBP	SREBP	NN	B-NP
O	532	535	was	be	VBD	B-VP
O	536	545	activated	activate	VBN	I-VP
O	546	552	during	during	IN	B-PP
B-Cell	553	556	ECs	EC	NNS	B-NP
O	557	566	migration	migration	NN	I-NP
O	566	567	.	.	.	O

O	568	575	Western	Western	NN	B-NP
O	576	580	blot	blot	NN	I-NP
O	581	589	analysis	analysis	NN	I-NP
O	590	602	demonstrated	demonstrate	VBD	B-VP
O	603	612	increased	increase	VBN	B-NP
O	613	619	active	active	JJ	I-NP
O	620	624	form	form	NN	I-NP
O	625	630	SREBP	SREBP	NN	I-NP
O	631	633	in	in	IN	B-PP
O	634	643	migrating	migrate	VBG	B-VP
O	644	646	as	as	IN	B-SBAR
O	647	655	compared	compare	VBN	B-VP
O	656	658	to	to	TO	B-PP
O	659	662	non	non	AFX	O
O	662	663	-	-	HYPH	O
O	663	672	migrating	migrate	VBG	B-VP
B-Cell	673	676	ECs	EC	NNS	B-NP
O	677	687	population	population	NN	I-NP
O	687	688	.	.	.	O

O	689	694	SREBP	SREBP	NN	B-NP
O	695	705	activation	activation	NN	I-NP
O	706	715	decreased	decrease	VBD	B-VP
O	716	718	as	as	IN	B-SBAR
B-Cell	719	722	ECs	EC	NNS	B-NP
O	723	732	migration	migration	NN	I-NP
O	733	739	slowed	slow	VBD	B-VP
O	739	740	;	;	:	O
O	740	741	(	(	(	B-LST
O	741	742	2	2	LS	I-LST
O	742	743	)	)	)	O
O	744	756	Coincidental	Coincidental	JJ	B-ADJP
O	757	761	with	with	IN	B-PP
O	762	767	SREBP	SREBP	NN	B-NP
O	768	778	activation	activation	NN	I-NP
O	778	779	,	,	,	O
O	780	784	mRNA	mRNA	NN	B-NP
O	785	795	expression	expression	NN	I-NP
O	796	798	of	of	IN	B-PP
O	799	802	its	its	PRP$	B-NP
O	803	809	target	target	NN	I-NP
O	810	815	genes	gene	NNS	I-NP
O	816	820	such	such	JJ	B-PP
O	821	823	as	as	IN	I-PP
O	824	827	low	low	JJ	B-NP
O	828	835	density	density	NN	I-NP
O	836	847	lipoprotein	lipoprotein	NN	I-NP
O	848	856	receptor	receptor	NN	I-NP
O	856	857	,	,	,	O
O	858	861	HMG	HMG	NN	B-NP
O	861	862	-	-	HYPH	I-NP
O	862	865	CoA	CoA	NN	I-NP
O	866	875	reductase	reductase	NN	I-NP
O	875	876	,	,	,	O
O	877	880	and	and	CC	O
O	881	886	fatty	fatty	JJ	B-NP
O	887	891	acid	acid	NN	I-NP
O	892	900	synthase	synthase	NN	I-NP
O	901	905	also	also	RB	B-ADVP
O	906	915	increased	increase	VBD	B-VP
O	916	918	in	in	IN	B-PP
O	919	928	migrating	migrate	VBG	B-VP
B-Cell	929	932	ECs	EC	NNS	B-NP
O	933	943	population	population	NN	I-NP
O	944	946	as	as	IN	B-SBAR
O	947	955	detected	detect	VBN	B-VP
O	956	958	by	by	IN	B-PP
O	959	963	real	real	JJ	B-NP
O	963	964	-	-	HYPH	I-NP
O	964	968	time	time	NN	I-NP
O	969	972	PCR	PCR	NN	I-NP
O	972	973	;	;	:	O
O	974	975	(	(	(	B-LST
O	975	976	3	3	LS	I-LST
O	976	977	)	)	)	O
O	978	987	Migration	Migration	NN	B-NP
O	988	995	induced	induce	VBD	B-VP
O	996	1001	SREBP	SREBP	NN	B-NP
O	1002	1012	activation	activation	NN	I-NP
O	1013	1015	in	in	IN	B-PP
B-Cell	1016	1019	ECs	EC	NNS	B-NP
O	1020	1023	was	be	VBD	B-VP
O	1024	1033	inhibited	inhibit	VBN	I-VP
O	1034	1036	by	by	IN	B-PP
O	1037	1042	SREBP	SREBP	NN	B-NP
O	1042	1043	-	-	HYPH	O
O	1043	1049	acting	act	VBG	B-NP
O	1050	1057	protein	protein	NN	I-NP
O	1058	1062	RNAi	RNAi	NN	I-NP
O	1063	1066	and	and	CC	O
O	1067	1084	pharmacologically	pharmacologically	RB	B-ADVP
O	1085	1087	by	by	IN	B-PP
O	1088	1090	25	25	CD	B-NP
O	1090	1091	-	-	HYPH	I-NP
O	1091	1109	hydroxycholesterol	hydroxycholesterol	NN	I-NP
O	1109	1110	;	;	:	O
O	1111	1112	(	(	(	B-LST
O	1112	1113	4	4	LS	I-LST
O	1113	1114	)	)	)	O
O	1115	1125	Inhibition	Inhibition	NN	B-NP
O	1126	1128	of	of	IN	B-PP
O	1129	1134	SREBP	SREBP	NN	B-NP
O	1135	1138	led	lead	VBD	B-VP
O	1139	1141	to	to	TO	B-PP
O	1142	1151	decreased	decrease	VBN	B-NP
B-Cell	1152	1155	ECs	EC	NNS	I-NP
O	1156	1165	migration	migration	NN	I-NP
O	1166	1168	in	in	IN	B-PP
O	1169	1176	various	various	JJ	B-NP
O	1177	1183	models	model	NNS	I-NP
O	1183	1184	;	;	:	O
O	1185	1186	(	(	(	B-LST
O	1186	1187	5	5	LS	I-LST
O	1187	1188	)	)	)	O
B-Cell	1189	1194	Cells	Cell	NNPS	B-NP
O	1195	1206	genetically	genetically	RB	B-ADJP
O	1207	1216	deficient	deficient	JJ	I-ADJP
O	1217	1219	in	in	IN	B-PP
O	1220	1225	SREBP	SREBP	NN	B-NP
O	1225	1226	-	-	HYPH	O
O	1226	1232	acting	act	VBG	B-VP
O	1233	1240	protein	protein	NN	B-NP
O	1240	1241	,	,	,	O
O	1242	1245	S1P	S1P	NN	B-NP
O	1245	1246	,	,	,	O
O	1247	1249	or	or	CC	O
O	1250	1253	S2P	S2P	NN	B-NP
O	1253	1254	,	,	,	O
O	1255	1269	phenotypically	phenotypically	RB	B-ADVP
O	1270	1279	exhibited	exhibit	VBD	B-VP
O	1280	1288	impaired	impaired	JJ	B-NP
O	1289	1298	migration	migration	NN	I-NP
O	1298	1299	;	;	:	O
O	1300	1301	(	(	(	O
O	1301	1302	6	6	CD	B-NP
O	1302	1303	)	)	)	O
O	1304	1309	SREBP	SREBP	NN	B-NP
O	1310	1320	inhibition	inhibition	NN	I-NP
O	1321	1323	in	in	IN	B-PP
B-Cell	1324	1327	ECs	EC	NNS	B-NP
O	1328	1338	suppressed	suppress	VBD	B-VP
O	1339	1342	the	the	DT	B-NP
O	1343	1351	activity	activity	NN	I-NP
O	1352	1354	of	of	IN	B-PP
O	1355	1360	small	small	JJ	B-NP
O	1361	1367	GTPase	GTPase	NN	I-NP
O	1368	1373	Cdc42	Cdc42	NN	I-NP
O	1373	1374	,	,	,	O
O	1375	1376	a	a	DT	B-NP
O	1377	1380	key	key	JJ	I-NP
O	1381	1389	molecule	molecule	NN	I-NP
O	1390	1393	for	for	IN	B-PP
B-Cell	1394	1397	ECs	EC	NNS	B-NP
O	1398	1406	motility	motility	NN	I-NP
O	1406	1407	.	.	.	O

O	1408	1419	CONCLUSIONS	CONCLUSIONS	NNS	B-NP
O	1419	1420	:	:	:	O
O	1421	1426	SREBP	SREBP	NN	B-NP
O	1427	1429	is	be	VBZ	B-VP
O	1430	1439	activated	activate	VBN	I-VP
O	1440	1446	during	during	IN	B-PP
O	1447	1450	and	and	CC	O
O	1451	1456	plays	play	VBZ	B-VP
O	1457	1458	a	a	DT	B-NP
O	1459	1467	critical	critical	JJ	I-NP
O	1468	1472	role	role	NN	I-NP
O	1473	1475	in	in	IN	B-PP
B-Cell	1476	1479	ECs	EC	NNS	B-NP
O	1480	1489	migration	migration	NN	I-NP
O	1489	1490	.	.	.	O

O	1491	1500	Targeting	Target	VBG	B-NP
O	1501	1506	SREBP	SREBP	NN	I-NP
O	1507	1512	could	could	MD	B-VP
O	1513	1519	become	become	VB	I-VP
O	1520	1521	a	a	DT	B-NP
O	1522	1527	novel	novel	JJ	I-NP
O	1528	1536	approach	approach	NN	I-NP
O	1537	1539	in	in	IN	B-PP
O	1540	1548	fighting	fight	VBG	B-VP
O	1549	1557	diseases	disease	NNS	B-NP
O	1558	1567	involving	involve	VBG	B-VP
O	1568	1576	abnormal	abnormal	JJ	B-NP
B-Cell	1577	1580	ECs	EC	NNS	I-NP
O	1581	1590	migration	migration	NN	I-NP
O	1590	1591	.	.	.	O

